FGFR1 and breast cancer: Furthermore, the importance of FGFR/FGF axis deregulation during relapse in the clinical setting of BC was shown by the analysis of patient samples obtained from the MONALEESA-2 trial: Patients with FGFR1 amplification progressed more rapidly compared to those patients with unaltered FGFR1 [80].